Literature DB >> 24211020

Chlorophenylpiperazine analogues as high affinity dopamine transporter ligands.

William C Motel1, Jason R Healy2, Eddy Viard2, Buddy Pouw3, Kelly Martin1, Rae R Matsumoto2,3, Andrew Coop1.   

Abstract

Selective σ2 ligands continue to be an active target for medications to attenuate the effects of psychostimulants. In the course of our studies to determine the optimal substituents in the σ2-selective phenyl piperazines analogues with reduced activity at other neurotransmitter systems, we discovered that 1-(3-chlorophenyl)-4-phenethylpiperazine actually had preferentially increased affinity for dopamine transporters (DAT), yielding a highly selective DAT ligand.
Copyright © 2013 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Cocaine; Dopamine transporter; Methamphetamine; Neurotransmitter; Sigma receptor; Structure–activity relationships

Mesh:

Substances:

Year:  2013        PMID: 24211020      PMCID: PMC3919026          DOI: 10.1016/j.bmcl.2013.09.038

Source DB:  PubMed          Journal:  Bioorg Med Chem Lett        ISSN: 0960-894X            Impact factor:   2.823


  31 in total

Review 1.  Agonist-like, replacement pharmacotherapy for stimulant abuse and dependence.

Authors:  John Grabowski; James Shearer; John Merrill; S Stevens Negus
Journal:  Addict Behav       Date:  2004-09       Impact factor: 3.913

Review 2.  The need for speed: an update on methamphetamine addiction.

Authors:  Alasdair M Barr; William J Panenka; G William MacEwan; Allen E Thornton; Donna J Lang; William G Honer; Tania Lecomte
Journal:  J Psychiatry Neurosci       Date:  2006-09       Impact factor: 6.186

3.  Effects of UMB24 and (+/-)-SM 21, putative sigma2-preferring antagonists, on behavioral toxic and stimulant effects of cocaine in mice.

Authors:  Rae R Matsumoto; Buddy Pouw; Aisha L Mack; Antawan Daniels; Andrew Coop
Journal:  Pharmacol Biochem Behav       Date:  2006-12-22       Impact factor: 3.533

Review 4.  Emerging pharmacological strategies in the fight against cocaine addiction.

Authors:  Mehmet Sofuoglu; Thomas R Kosten
Journal:  Expert Opin Emerg Drugs       Date:  2006-03       Impact factor: 4.191

5.  Involvement of sigma (sigma) receptors in the acute actions of methamphetamine: receptor binding and behavioral studies.

Authors:  Emily C Nguyen; Kari A McCracken; Yun Liu; Buddy Pouw; Rae R Matsumoto
Journal:  Neuropharmacology       Date:  2005-10       Impact factor: 5.250

6.  The dopamine inhibitor GBR 12909: selectivity and molecular mechanism of action.

Authors:  P H Andersen
Journal:  Eur J Pharmacol       Date:  1989-08-03       Impact factor: 4.432

7.  Differential effects of sigma1 receptor blockade on self-administration and conditioned reinstatement motivated by cocaine vs natural reward.

Authors:  Rémi Martin-Fardon; Tangui Maurice; Harinder Aujla; Wayne D Bowen; Friedbert Weiss
Journal:  Neuropsychopharmacology       Date:  2007-01-31       Impact factor: 7.853

8.  The binding sites for cocaine and dopamine in the dopamine transporter overlap.

Authors:  Thijs Beuming; Julie Kniazeff; Marianne L Bergmann; Lei Shi; Luis Gracia; Klaudia Raniszewska; Amy Hauck Newman; Jonathan A Javitch; Harel Weinstein; Ulrik Gether; Claus J Loland
Journal:  Nat Neurosci       Date:  2008-06-22       Impact factor: 24.884

Review 9.  New treatments for cocaine dependence: a focused review.

Authors:  Laurent Karila; David Gorelick; Aviv Weinstein; Florence Noble; Amine Benyamina; Sarah Coscas; Lisa Blecha; William Lowenstein; Jean Luc Martinot; Michel Reynaud; Jean Pierre Lépine
Journal:  Int J Neuropsychopharmacol       Date:  2007-10-10       Impact factor: 5.176

Review 10.  New developments in the pharmacotherapy of cocaine abuse.

Authors:  Antonio Preti
Journal:  Addict Biol       Date:  2007-06       Impact factor: 4.280

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.